10 research outputs found

    The antiferromagnetic Ising model for a bilayer Bethe lattice

    No full text
    The totally antiferromagnetic Ising model is analyzed on a bilayer Bethe lattice in detail by studying the order-parameters, response functions, i.e. susceptibility and specific heat, and free energy by using the recursion relations in a pairwise approach. The ground state phase diagrams of the model are also obtained on the (J(2)/vertical bar J(1)vertical bar,J(3)/q vertical bar J(1)vertical bar) plane for given values of H/q vertical bar J(1)vertical bar and on the (H/q vertical bar J(1)vertical bar,J(3)/q vertical bar J(1)vertical bar) plane for given J(2)/vertical bar J(1)vertical bar. As a result, we have obtained the temperature-dependent phase diagrams for various values of the coordination number q on the (J(3)/vertical bar J(1)vertical bar,kT/vertical bar J(1)vertical bar) and (H/vertical bar J(1)vertical bar,kT/vertical bar J(1)vertical bar) planes for given values of the rest of the system parameters. (C) 2008 Elsevier B.V. All rights reserved

    Solid-State Dye-Sensitized Solar Cells Using Red and Near-IR Absorbing Bodipy Sensitizers

    No full text
    WOS: 000281180700022PubMed ID: 20704314Boron-dipyrrin dyes, through rational design, yield promising new materials. With strong electron-donor functionalities and anchoring groups for attachment to nanocrystalline TiO(2), these dyes proved useful as sensitizers in dye-sensitized solar cells. Their applicability in a solid-state electrolyte regime offers additional opportunities for practical applications

    Levodopa-Loaded 3D-Printed Poly (Lactic) Acid/Chitosan Neural Tissue Scaffold as a Promising Drug Delivery System for the Treatment of Parkinson’s Disease

    No full text
    Parkinson’s disease, the second most common neurodegenerative disease in the world, develops due to decreased dopamine levels in the basal ganglia. Levodopa, a dopamine precursor used in the treatment of Parkinson’s disease, can be used as a drug delivery system. This study presents an approach to the use of 3D-printed levodopa-loaded neural tissue scaffolds produced with polylactic acid (PLA) and chitosan (CS) for the treatment of Parkinson’s disease. Surface morphology and pore sizes were examined by scanning electron microscopy (SEM). Average pore sizes of 100–200 µm were found to be ideal for tissue engineering scaffolds, allowing cell penetration but not drastically altering the mechanical properties. It was observed that the swelling and weight loss behaviors of the scaffolds increased after the addition of CS to the PLA. Levodopa was released from the 3D-printed scaffolds in a controlled manner for 14 days, according to a Fickian diffusion mechanism. Mesenchymal stem cells (hAD-MSCs) derived from human adipose tissue were used in MTT analysis, fluorescence microscopy and SEM studies and confirmed adequate biocompatibility. Overall, the obtained results show that PLA/CS 3D-printed scaffolds have an alternative use for the levodopa delivery system for Parkinson’s disease in neural tissue engineering applications
    corecore